Aurora Cannabis (TSE:ACB) Shares Up 1% – Should You Buy?

Aurora Cannabis Inc. (TSE:ACB) shares shot up 1% during trading on Wednesday . The company traded as high as C$5.36 and last traded at C$5.25. 246,930 shares traded hands during trading, a decline of 49% from the average session volume of 480,419 shares. The stock had previously closed at C$5.20.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on ACB shares. ATB Cormark Capital Markets reduced their price objective on shares of Aurora Cannabis from C$9.00 to C$8.50 and set an “outperform” rating for the company in a report on Thursday, December 11th. Canaccord Genuity Group set a C$10.00 price target on shares of Aurora Cannabis and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of C$9.25.

Aurora Cannabis Price Performance

The company has a current ratio of 3.42, a quick ratio of 2.48 and a debt-to-equity ratio of 18.72. The business’s fifty day moving average is C$5.64 and its 200 day moving average is C$6.51. The firm has a market capitalization of C$297.72 million, a P/E ratio of -3.50 and a beta of 0.56.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.